ImmunoPrecise Antibodies (IPA) Q4 2025 Earnings Call July 29, 2025 10:30 AM ET Company ParticipantsJennifer Bath - CEO, President & Non-Independent DirectorJoseph Scheffler - Interim CFOConference Call ParticipantsRamakanth Swayampakula - MD & Senior Healthcare AnalystOperatorGood morning, ladies and gentlemen, and thank you for joining us today for ImmunoPrecise Antibody's Fourth Quarter and Fiscal Year End twenty twenty five Earnings Call. We appreciate your time and interest in IPA. Today's call will be ...